Press release
Digital Biomarkers Market is expected to reach US$ 26.69 Billion by 2033 | Koneksa Health, Altoida Inc, Empatica Inc, Evidation Health, Inc., ActiGraph LLC, Quartet Health, IXICO plc
Digital Biomarkers Market - DataM Intelligence
The Digital Biomarkers Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. By combining qualitative and quantitative research methodologies, the firm delivers in-depth reports that help clients navigate complex market dynamics, drive strategic growth, and seize new opportunities in an ever-evolving global landscape.
Download your exclusive sample report today: (corporate email gets priority access): https://datamintelligence.com/download-sample/digital-biomarkers-market?sg
Digital Biomarkers Market Landscape Analysis:
Digital biomarkers are measurable, data-driven indicators of health collected using digital tools such as wearable devices, smartphones, sensors, and mobile health applications. They play a vital role in continuously monitoring health status, tracking disease progression, and evaluating responses to treatment in real-time settings.
These biomarkers capture a wide range of physiological and behavioral data, including heart rate, blood pressure, glucose levels, sleep quality, physical activity, and cognitive function. In addition, they are increasingly being used to detect subtle changes in voice or speech patterns-useful in managing neurological disorders-as well as gait analysis for mobility impairments. Other applications include tracking eye movements and facial expressions to assess changes in mental health, enabling earlier and more precise interventions.
Digital Biomarkers Market: Shifting Industry Trends and Market Potential
Surging Adoption of Wearables and Mobile Health Tech Fueling Market Growth
The accelerating use of wearable technology and mobile health applications is a major catalyst for the expansion of the global digital biomarkers market. As chronic illnesses such as cardiovascular diseases, diabetes, and neurological disorders become more prevalent, the need for continuous and real-time health monitoring is growing rapidly. Wearables-including smartwatches, fitness bands, and biosensors-enable the collection of valuable physiological data, which supports early diagnosis, tailored therapies, and better patient care outcomes.
This shift is not only transforming personal health management but also broadening the application of digital biomarkers in both clinical and remote healthcare environments.
A notable development occurred in December 2024, when ElectronRx a prominent player in digital medicine-introduced purpleDx, a cardiopulmonary assessment application showcased at CES 2025. Designed to meet medical device regulatory standards, purpleDx allows patients with chronic respiratory conditions to track digital lung function biomarkers from the comfort of their homes. The app delivers real-time data to healthcare providers, helping personalize treatment strategies and enhance overall care. Developed in collaboration with respiratory clinics and the European Pulmonary Hypertension Association, purpleDx is aimed at monitoring and managing conditions such as asthma, COPD, interstitial lung disease, and pulmonary hypertension.
Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/digital-biomarkers-market?sg
Strategic Players Driving the Digital Biomarkers Market Forward: Koneksa Health, Altoida Inc, Empatica Inc, Evidation Health, Inc., ActiGraph LLC, Quartet Health, IXICO plc, Vivo Sense, Aural Analytic, Neurotrack Technologies Inc.
Research Methodology:
The global Digital Biomarkers Market research report employs a comprehensive dual-source approach, integrating both primary and secondary data collection methods to ensure robust market analysis. Our research framework systematically evaluates multiple industry-influencing variables, including regulatory frameworks and government policies, prevailing market conditions, competitive intensity levels, historical performance data, current market positioning, technological innovations and disruptions, emerging industry developments, cross-sector business impacts, market volatility patterns, growth prospects, potential market barriers, and strategic challenges facing industry participants.
Segment Covered in the Digital Biomarkers Market:
By System Component (Wearable Devices, Mobile Applications, Sensors, Digital Platforms, Data Integration & Analytics Platforms, Others)
By Application (Cardiovascular Diseases, Neurological Disorders, Respiratory Disorders, Metabolic Disorders, Gastrointestinal Disorders, Others)
By End User (Pharmaceutical Companies, Healthcare Providers, Payers, Academic & Research Institutions, Others)
Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription?sg
Industry Developments:
Biofourmis Expands Global Reach:
In February 2024, Biofourmis, a recognized leader in digital biomarkers and decentralized clinical trial solutions, announced four new strategic collaborations with major pharmaceutical companies. These partnerships aim to enhance clinical research initiatives across key regions including the United States, Europe, Asia-Pacific, and the Middle East & Africa (MEA), leveraging Biofourmis' advanced digital biomarker platform to improve data-driven decision-making in trials.
Indivi and Biogen Collaborate on Parkinson's Research:
In March 2024, Indivi entered into a partnership with Biogen to advance the development of digital biomarkers for Parkinson's disease. The collaboration centers around the Konectom platform, which is being used in the Phase 2b LUMA clinical trial. This study assesses the safety and efficacy of BIIB122 for early-stage Parkinson's patients and is conducted in collaboration with Denali Therapeutics Inc. The initiative highlights the growing role of digital tools in neurodegenerative disease research and patient monitoring.
Regional Analysis for Digital Biomarkers Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Most Frequently Asked Questions in the Digital Biomarkers Market Research Industry:
➠ Who leads the Digital Biomarkers industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Digital Biomarkers market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Digital Biomarkers market growth?
➠ What are the dominant sales and distribution strategies in the Digital Biomarkers industry?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Digital Biomarkers Market is expected to reach US$ 26.69 Billion by 2033 | Koneksa Health, Altoida Inc, Empatica Inc, Evidation Health, Inc., ActiGraph LLC, Quartet Health, IXICO plc here
News-ID: 4097242 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Epistaxis Market is projected to reach around US$ 289.30 million by 2032 | GSK p …
The epistaxis market was valued at approximately US$ 194.48 million in 2024 and is projected to reach around US$ 289.30 million by 2032, expanding at a compound annual growth rate (CAGR) of 5.3% during the forecast period from 2025 to 2032.
The Epistaxis Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence…
Balloon Catheters Market is projected to grow to US$ 8.65 billion by 2031 | Nord …
The balloon catheters market was valued at approximately US$ 4.58 billion in 2022 and is projected to grow significantly, reaching around US$ 8.65 billion by 2031. The market is expected to expand at a compound annual growth rate (CAGR) of 8.7% during the forecast period from 2024 to 2031.
The Balloon Catheters Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges.…
Orthopaedic Devices Market Size, Share, Industry Growth Report 2024-2031 | AGIS …
Orthopaedic Devices Market is estimated to grow at a CAGR of 5.3% during the forecast period 2024-2031.
The Orthopaedic Devices Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. By combining qualitative and quantitative research methodologies, the firm delivers in-depth…
Orthopaedic Implants Market is projected to grow to USD 71.6 billion by 2030 | Z …
The orthopedic implants market was valued at USD 44.7 billion in 2022 and is expected to experience significant growth, reaching approximately USD 71.6 billion by 2030. The market is anticipated to expand at a compound annual growth rate (CAGR) of 6.2% over the forecast period from 2024 to 2031.
The Orthopaedic Implants Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges.…
More Releases for Digital
Introducing Digital Sales Pro, Inc: Revolutionizing Digital Sales in the Digital …
Digital Sales Pro, Inc. is a company that helps content creators and publishers make money from content and reach a larger audience with their craft.
In today's world, it can be tough for content creators and publishers to make money and connect with their audience.
At, Digital Sales Pro, Inc. we understand these challenges and have created a suite of solutions that help our clients build a strong online presence, monetize…
Digital Twin in Healthcare Market Analysis By Type - Product Digital Twins, Proc …
Introduction
The healthcare industry has seen significant growth and development over the years, with technology playing a critical role in transforming patient care. One such innovative technology that has emerged in recent years is the Global Digital Twin in Healthcare Market. This technology allows healthcare professionals to create a virtual replica of a patient's physical self, enabling them to monitor and analyze patient data in real-time. The Global Digital Twin in…
Digital Twin in Healthcare Market Analysis By Type - Product Digital Twins, Proc …
In 2021, the market for Digital Twin in Healthcare worldwide was worth $6.75 billion US dollars. AMR Group projects that the market will reach US$ 96.5 billion by 2031, growing at a CAGR of 40 percent between 2022 and 2031.
Industry Overview
Digital twins are virtual copies of physical objects or things that data scientist & IT professionals can use to compute simulations prior to developing and deploying the original devices. Digital…
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant…
Digital Advertising on Mobil Market Analysis 2019 Top Growing Companies: Adverti …
Digital Advertising on Mobil Market
Digital Advertising on Mobile Market is a type of advertising that shows that mobile devices such as smart phones and tablets have wireless connectivity. For mobile devices with fewer lenses than computers or laptops, digital media formats are often the most suitable for small displays through outputs. Telephone advertising is the communication of products or services of mobile devices and consumers. Telephone announcements range from…
Digital Display Market Future Growth with Worldwide Players (Digital Virgo, Digi …
Digital Display Industry 2019 Global Market 2025 research report represents the historical overview of current Market situation, size, share, trends, growth, supply, outlook and manufacturers with detailed analysis. It also focuses on Digital Display volume and value at global level, regional level and company level. From a global perspective, this report represents overall Digital Display market size by analyzing historical data and future prospect.
Get Sample Copy of this Report -…
